Results 121 to 130 of about 4,243,211 (352)

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Effect of HINS light on the contraction of fibroblast populated collagen lattices [PDF]

, 2009
High intensity narrow spectrum (HINS) light has been shown to have bactericidal effects on a range of medically important bacteria[1]. HINS technology could potentially be useful as a method for disinfecting medical implants, tissue engineered constructs
Anderson, J.G., Grant, M.H., MacGregor, S.J., Maclean, M., McDonald, R.   +4 more
core  

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

School of Medical Laboratory Technician, Nkpor 2023/2024 Application Form, is out call ☎07065-892637 DR GRACE (07065-892637) GAINING APPLICATION INTO THE COLLEGES OF HEALTH TECHNOLOGY Application into the Colleges is through Entrance Examination and interview. All intending students must purchase the application form of the school when it is on sale and submit directly to the institution, write the examination and if successful go for the interview and be admitted

, 2023
banke
openalex   +2 more sources

ChatGPT Related Technology and Its Applications in the Medical Field [PDF]

, 2023
BS Tairui Zhang, MD Linxue Qian
openalex   +1 more source

Improvements in medical care and technology and reductions in traffic-related fatalities in Great Britain [PDF]

Traffic-related fatalities in the UK have fallen dramatically over the last 30 years by about 50%. This decline has been observed in many other developed countries with similar rates of reduction.
Noland, Robert, Quddus, Mohammed Abdul
core  

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

A Review of Three-Dimensional Printing Technology for Medical Applications [PDF]

, 2019
Sangwook Lee, Taehun Kim, Dayeong Hong, Junhyeok Ock, Jaeyoung Kwon, Eunseo Gwon, Jinhee Kwon, Joon Beom Seo, Eun Jin Chae, Dong Hyun Yang, Choung‐Soo Kim, Yoon Soo Kyung, Beom Seok Ko, Sehoon Choi, Ho‐Seok Sa, Namkug Kim   +15 more
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source